Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Cotransduction of tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes into cultured striatal cells using adeno-associated virus vectors.

Fan D, Kang D, Ogawa M, Nakano I, Nagatsu T, Kurtzman GJ, Ozawa K.

Chin Med J (Engl). 1998 Dec;111(12):1111-3.

PMID:
11263376
2.

In vivo marking of rhesus monkey lymphocytes by adeno-associated viral vectors: direct comparison with retroviral vectors.

Hanazono Y, Brown KE, Handa A, Metzger ME, Heim D, Kurtzman GJ, Donahue RE, Dunbar CE.

Blood. 1999 Oct 1;94(7):2263-70.

PMID:
10498598
3.

Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors.

Lipkowitz MS, Hanss B, Tulchin N, Wilson PD, Langer JC, Ross MD, Kurtzman GJ, Klotman PE, Klotman ME.

J Am Soc Nephrol. 1999 Sep;10(9):1908-15.

4.

Efficient production of adeno-associated virus vectors using split-type helper plasmids.

Ogasawara Y, Urabe M, Kogure K, Kume A, Colosi P, Kurtzman GJ, Ozawa K.

Jpn J Cancer Res. 1999 Apr;90(4):476-83.

5.

Charged-to-alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein.

Urabe M, Hasumi Y, Kume A, Surosky RT, Kurtzman GJ, Tobita K, Ozawa K.

J Virol. 1999 Apr;73(4):2682-93.

6.

Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus.

Watson GL, Sayles JN, Chen C, Elliger SS, Elliger CA, Raju NR, Kurtzman GJ, Podsakoff GM.

Gene Ther. 1998 Dec;5(12):1642-9.

7.

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector.

Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA, Burton M, Bellinger DA, Read MS, Brinkhous KM, Podsakoff GM, Nichols TC, Kurtzman GJ, High KA.

Nat Med. 1999 Jan;5(1):56-63.

PMID:
9883840
8.

Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors.

Fan DS, Ogawa M, Fujimoto KI, Ikeguchi K, Ogasawara Y, Urabe M, Nishizawa M, Nakano I, Yoshida M, Nagatsu I, Ichinose H, Nagatsu T, Kurtzman GJ, Ozawa K.

Hum Gene Ther. 1998 Nov 20;9(17):2527-35.

PMID:
9853519
9.

Adeno-associated virus vectors can be efficiently produced without helper virus.

Matsushita T, Elliger S, Elliger C, Podsakoff G, Villarreal L, Kurtzman GJ, Iwaki Y, Colosi P.

Gene Ther. 1998 Jul;5(7):938-45.

10.

Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro.

Fan D, Ogawa M, Ikeguchi K, Fujimoto K, Urabe M, Kume A, Nishizawa M, Matsushita N, Kiuchi K, Ichinose H, Nagatsu T, Kurtzman GJ, Nakano I, Ozawa K.

Neurosci Lett. 1998 May 22;248(1):61-4.

PMID:
9665664
11.

Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver.

Nakai H, Herzog RW, Hagstrom JN, Walter J, Kung SH, Yang EY, Tai SJ, Iwaki Y, Kurtzman GJ, Fisher KJ, Colosi P, Couto LB, High KA.

Blood. 1998 Jun 15;91(12):4600-7.

PMID:
9616156
12.

Robust, but transient expression of adeno-associated virus-transduced genes during human T lymphopoiesis.

Gardner JP, Zhu H, Colosi PC, Kurtzman GJ, Scadden DT.

Blood. 1997 Dec 15;90(12):4854-64.

PMID:
9389702
13.

A novel dicistronic AAV vector using a short IRES segment derived from hepatitis C virus genome.

Urabe M, Hasumi Y, Ogasawara Y, Matsushita T, Kamoshita N, Nomoto A, Colosi P, Kurtzman GJ, Tobita K, Ozawa K.

Gene. 1997 Oct 24;200(1-2):157-62.

PMID:
9373150
14.

Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome.

Surosky RT, Urabe M, Godwin SG, McQuiston SA, Kurtzman GJ, Ozawa K, Natsoulis G.

J Virol. 1997 Oct;71(10):7951-9.

16.

Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line.

Malik P, McQuiston SA, Yu XJ, Pepper KA, Krall WJ, Podsakoff GM, Kurtzman GJ, Kohn DB.

J Virol. 1997 Mar;71(3):1776-83.

17.

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.

Kessler PD, Podsakoff GM, Chen X, McQuiston SA, Colosi PC, Matelis LA, Kurtzman GJ, Byrne BJ.

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14082-7.

18.

Human parvovirus B19 infection.

Carper E, Kurtzman GJ.

Curr Opin Hematol. 1996 Mar;3(2):111-7. Review.

PMID:
9372060
19.

Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS.

J Clin Invest. 1989 Oct;84(4):1114-23.

20.

Feline parvovirus propagates in cat bone marrow cultures and inhibits hematopoietic colony formation in vitro.

Kurtzman GJ, Platanias L, Lustig L, Frickhofen N, Young NS.

Blood. 1989 Jul;74(1):71-81.

PMID:
2546625
21.

Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia.

Kurtzman GJ, Cohen B, Meyers P, Amunullah A, Young NS.

Lancet. 1988 Nov 19;2(8621):1159-62.

PMID:
2903376
22.

Laboratory infection with parvovirus B19.

Cohen BJ, Couroucé AM, Schwarz TF, Okochi K, Kurtzman GJ.

J Clin Pathol. 1988 Sep;41(9):1027-8. No abstract available.

23.

B19 parvovirus replicates in circulating cells of acutely infected patients.

Kurtzman GJ, Gascon P, Caras M, Cohen B, Young NS.

Blood. 1988 May;71(5):1448-54.

PMID:
2833960
24.

Chronic bone marrow failure due to persistent B19 parvovirus infection.

Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS.

N Engl J Med. 1987 Jul 30;317(5):287-94. No abstract available.

PMID:
3037373

Supplemental Content

Loading ...
Support Center